{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:38:57Z","timestamp":1780105137985,"version":"3.54.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","nanomedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.nano.2017.11.009","type":"journal-article","created":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T05:17:15Z","timestamp":1511241435000},"page":"339-351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses"],"prefix":"10.1016","volume":"14","author":[{"given":"N\u00faria","family":"Climent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Marradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Chiodo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Miralles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Jos\u00e9","family":"Maleno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Gatell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad","family":"Penad\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Plana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nano.2017.11.009_bb0005","first-page":"387","article-title":"HIV vaccines: progress to date","volume":"71","author":"Munier","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.nano.2017.11.009_bb0010","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.coviro.2016.02.010","article-title":"Approaches to preventative and therapeutic HIV vaccines","volume":"17","author":"Gray","year":"2016","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.nano.2017.11.009_bb0015","doi-asserted-by":"crossref","first-page":"20497","DOI":"10.7448\/IAS.18.1.20497","article-title":"Evaluating the efficacy of therapeutic HIV vaccines through analytical treatment interruptions","volume":"18","author":"Graziani","year":"2015","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/j.nano.2017.11.009_bb0020","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/327473a0","article-title":"Prospects for the control of AIDS by immunizing seropositive individuals","volume":"327","author":"Salk","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.nano.2017.11.009_bb0025","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.2217\/nnm.14.172","article-title":"Dendrimers as nonviral vectors in dendritic cell-based immunotherapies against human immunodeficiency virus: steps toward their clinical evaluation","volume":"9","author":"Vacas-C\u00f3rdoba","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2017.11.009_bb0030","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.it.2007.03.008","article-title":"Duration, combination and timing: the signal integration model of dendritic cell activation","volume":"28","author":"Macagno","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.nano.2017.11.009_bb0035","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1016\/j.vaccine.2014.09.010","article-title":"Loading dendritic cells with PLA-p24 nanoparticles or MVA expressing HIV genes induces HIV-1-specific T cell responses","volume":"32","author":"Climent","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2017.11.009_bb0040","doi-asserted-by":"crossref","first-page":"166ra2","DOI":"10.1126\/scitranslmed.3004682","article-title":"A dendritic cell-based vaccine elicits T cell responses associated with control of HIV-1 replication","volume":"5","author":"Garc\u00eda","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.nano.2017.11.009_bb0045","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.4161\/hv.25876","article-title":"Dendritic cell based vaccines for HIV infection: the way ahead","volume":"9","author":"Garc\u00eda","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.nano.2017.11.009_bb0050","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.biomaterials.2015.10.034","article-title":"Directing vaccine immune responses to mucosa by nanosized particulate carriers encapsulating NOD ligands","volume":"75","author":"Pavot","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2017.11.009_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-immunol-100311-102839","article-title":"Decisions about dendritic cells: past, present, and future","volume":"30","author":"Steinman","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.nano.2017.11.009_bb0060","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.cell.2010.09.039","article-title":"Microbial stimulation fully differentiates monocytes to DC-SIGN\/CD209(+) dendritic cells for immune T cell areas","volume":"143","author":"Cheong","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.nano.2017.11.009_bb0065","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1126\/science.1178331","article-title":"Development of monocytes, macrophages, and dendritic cells","volume":"327","author":"Geissmann","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.nano.2017.11.009_bb0070","doi-asserted-by":"crossref","first-page":"e19644","DOI":"10.1371\/journal.pone.0019644","article-title":"Dendritic cells exposed to MVA-based HIV-1 vaccine induce highly functional HIV-1-specific CD8(+) T cell responses in HIV-1-infected individuals","volume":"6","author":"Climent","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.nano.2017.11.009_bb0075","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.carres.2014.07.012","article-title":"Assembling different antennas of the gp120 high mannose-type glycans on gold nanoparticles provides superior binding to the anti-HIV antibody 2G12 than the individual antennas","volume":"405","author":"Chiodo","year":"2015","journal-title":"Carbohydr Res"},{"key":"10.1016\/j.nano.2017.11.009_bb0080","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.addr.2009.11.017","article-title":"Nanotechnology-based systems for the treatment and prevention of HIV\/AIDS","volume":"62","author":"das Neves","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2017.11.009_bb0085","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1016\/j.vaccine.2015.08.025","article-title":"Nanovaccines for malaria using plasmodium falciparum antigen Pfs25 attached gold nanoparticles","volume":"33","author":"Kumar","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.nano.2017.11.009_bb0090","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.biomaterials.2009.09.032","article-title":"The use of PEGylated poly [2-(N,N-dimethylamino) ethyl methacrylate] as a mucosal DNA delivery vector and the activation of innate immunity and improvement of HIV-1-specific immune responses","volume":"31","author":"Qiao","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.nano.2017.11.009_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/1040841X.2015.1018131","article-title":"Strategic role of selected noble metal nanoparticles in medicine","author":"Rai","year":"2015","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.nano.2017.11.009_bb0100","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.addr.2016.02.010","article-title":"Role of nanotechnology in HIV\/AIDS vaccine development","volume":"103","author":"Liu","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.nano.2017.11.009_bb0105","first-page":"857","article-title":"Applications of gold nanoparticles in Nanomedicine: recent advances in vaccines","volume":"22","author":"Carabineiro","year":"2017","journal-title":"Mol Basel Switz"},{"key":"10.1016\/j.nano.2017.11.009_bb0110","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1021\/nl300027p","article-title":"Surface-engineered gold nanorods: promising DNA vaccine adjuvant for HIV-1 treatment","volume":"12","author":"Xu","year":"2012","journal-title":"Nano Lett"},{"key":"10.1016\/j.nano.2017.11.009_bb0115","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2217\/nnm.11.151","article-title":"Gold nanoparticles as carriers for a synthetic Streptococcus Pneumoniae type 14 conjugate vaccine","volume":"7","author":"Safari","year":"2012","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2017.11.009_bb0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2217\/nnm-2016-0306","article-title":"Preparation and immunogenicity of gold glyco-nanoparticles as antipneumococcal vaccine model","volume":"12","author":"Vetro","year":"2016","journal-title":"Nanomedicine"},{"key":"10.1016\/j.nano.2017.11.009_bb0125","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.nano.2014.08.005","article-title":"A gold nanoparticle-linked glycoconjugate vaccine against Burkholderia mallei","volume":"11","author":"Gregory","year":"2015","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"key":"10.1016\/j.nano.2017.11.009_bb0130","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1021\/bc200606s","article-title":"Design and synthesis of multifunctional gold nanoparticles bearing tumor-associated glycopeptide antigens as potential cancer vaccines","volume":"23","author":"Brin\u00e3s","year":"2012","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nano.2017.11.009_bb0135","doi-asserted-by":"crossref","first-page":"9362","DOI":"10.1021\/ja4046857","article-title":"\u2018Multicopy multivalent\u2019 glycopolymer-stabilized gold nanoparticles as potential synthetic cancer vaccines","volume":"135","author":"Parry","year":"2013","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.nano.2017.11.009_bb0140","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1039\/c2cs35420a","article-title":"Glyconanoparticles as multifunctional and multimodal carbohydrate systems","volume":"42","author":"Marradi","year":"2013","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.nano.2017.11.009_bb0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nri2674","article-title":"The immune response during acute HIV-1 infection: clues for vaccine development","volume":"10","author":"McMichael","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.nano.2017.11.009_bb0150","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev-med-052912-123749","article-title":"Lessons from the RV144 Thai phase III HIV-1 vaccine trial and the search for correlates of protection","volume":"66","author":"Kim","year":"2015","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.nano.2017.11.009_bb0155","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1182\/blood.V98.8.2482","article-title":"HIV gp120 receptors on human dendritic cells","volume":"98","author":"Turville","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.nano.2017.11.009_bb0160","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/0959-440X(95)80052-2","article-title":"Increasing diversity of animal lectin structures","volume":"5","author":"Drickamer","year":"1995","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.nano.2017.11.009_bb0165","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1084\/jem.164.6.2101","article-title":"Role of envelope glycoprotein carbohydrate in human immunodeficiency virus (HIV) infectivity and virus-induced cell fusion","volume":"164","author":"Lifson","year":"1986","journal-title":"J Exp Med"},{"key":"10.1016\/j.nano.2017.11.009_bb0170","first-page":"9874","article-title":"Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN","volume":"15","author":"Mart\u00ednez-Avila","year":"2009","journal-title":"Chem Weinh Bergstr Ger"},{"key":"10.1016\/j.nano.2017.11.009_bb0175","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1021\/bm801492c","article-title":"Polyester nanoparticles presenting mannose residues: toward the development of new vaccine delivery systems combining biodegradability and targeting properties","volume":"10","author":"Rieger","year":"2009","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.nano.2017.11.009_bb0180","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2015.01.040","article-title":"Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens","volume":"203","author":"Fehres","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2017.11.009_bb0185","doi-asserted-by":"crossref","first-page":"e23040","DOI":"10.4161\/onci.23040","article-title":"Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines","volume":"2","author":"Garc\u00eda-Vallejo","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.nano.2017.11.009_bb0190","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1002\/cbic.200900294","article-title":"Multivalent manno-glyconanoparticles inhibit DC-SIGN-mediated HIV-1 trans-infection of human T cells","volume":"10","author":"Mart\u00ednez-Avila","year":"2009","journal-title":"Chembiochem Eur J Chem Biol"},{"key":"10.1016\/j.nano.2017.11.009_bb0195","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1021\/bc200663r","article-title":"Cellular uptake of gold nanoparticles bearing HIV gp120 oligomannosides","volume":"23","author":"Arn\u00e1iz","year":"2012","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nano.2017.11.009_bb0200","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2016.06.019","article-title":"Self-assembling peptide for co-delivery of HIV-1 CD8+ T cells epitope and toll-like receptor 7\/8 agonists R848 to induce maturation of monocyte derived dendritic cell and augment polyfunctional cytotoxic T lymphocyte (CTL) response","volume":"236","author":"Ding","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2017.11.009_bb0205","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.4049\/jimmunol.172.9.5249","article-title":"The HIV-1 HLA-A2-SLYNTVATL is a help-independent CTL epitope","volume":"172","author":"Kan-Mitchell","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2017.11.009_bb0210","doi-asserted-by":"crossref","first-page":"e169","DOI":"10.1371\/journal.ppat.0030169","article-title":"HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells","volume":"3","author":"Shan","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.nano.2017.11.009_bb0215","doi-asserted-by":"crossref","first-page":"S142","DOI":"10.1093\/infdis\/jiw637","article-title":"In vivo models of human immunodeficiency virus persistence and cure strategies","volume":"215","author":"Nixon","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.nano.2017.11.009_bb0220","doi-asserted-by":"crossref","first-page":"5314","DOI":"10.1128\/JVI.02329-09","article-title":"Preclinical studies of a modified vaccinia virus Ankara-based HIV candidate vaccine: antigen presentation and antiviral effect","volume":"84","author":"Brandler","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.nano.2017.11.009_bb0225","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1039\/b909022n","article-title":"A step-heating procedure for the synthesis of high-quality FePt nanostars","volume":"11","author":"He","year":"2009","journal-title":"CrstEngComm"},{"key":"10.1016\/j.nano.2017.11.009_bb0230","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.nano.2007.03.005","article-title":"Cell selective response to gold nanoparticles","volume":"3","author":"Patra","year":"2007","journal-title":"Nanomedicine Nanotechnol Biol Med"},{"key":"10.1016\/j.nano.2017.11.009_bb0235","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jmb.2011.03.042","article-title":"Gold nanoparticles coated with oligomannosides of HIV-1 glycoprotein gp120 mimic the carbohydrate epitope of antibody 2G12","volume":"410","author":"Marradi","year":"2011","journal-title":"J Mol Biol"},{"key":"10.1016\/j.nano.2017.11.009_bb0240","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/cbic.200700310","article-title":"Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells","volume":"9","author":"Adams","year":"2008","journal-title":"Chembiochem Eur J Chem Biol"},{"key":"10.1016\/j.nano.2017.11.009_bb0245","doi-asserted-by":"crossref","first-page":"e46959","DOI":"10.1371\/journal.pone.0046959","article-title":"Mannosylated mucin-type immunoglobulin fusion proteins enhance antigen-specific antibody and T lymphocyte responses","volume":"7","author":"Ahl\u00e9n","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nano.2017.11.009_bb0250","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1365-2567.2006.02384.x","article-title":"Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells","volume":"118","author":"Sheng","year":"2006","journal-title":"Immunology"},{"key":"10.1016\/j.nano.2017.11.009_bb0255","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.molimm.2017.09.001","article-title":"Targeting dendritic cells through gold nanoparticles: a review on the cellular uptake and subsequent immunological properties","volume":"91","author":"Ahmad","year":"2017","journal-title":"Mol Immunol"},{"key":"10.1016\/j.nano.2017.11.009_bb0260","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1021\/mp400717r","article-title":"Tracking targeted bimodal nanovaccines: immune responses and routing in cells, tissue, and whole organism","volume":"11","author":"Cruz","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nano.2017.11.009_bb0265","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/17435390.2017.1306131","article-title":"Non-specific adsorption of complement proteins affects complement activation pathways of gold nanomaterials","volume":"11","author":"Quach","year":"2017","journal-title":"Nanotoxicology"},{"key":"10.1016\/j.nano.2017.11.009_bb0270","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jconrel.2014.11.033","article-title":"In vivo delivery of peptides and toll-like receptor ligands by mannose-functionalized polymeric nanoparticles induces prophylactic and therapeutic anti-tumor immune responses in a melanoma model","volume":"198","author":"Silva","year":"2015","journal-title":"J Control Release"},{"key":"10.1016\/j.nano.2017.11.009_bb0275","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/cmi.2010.44","article-title":"IL-15 increases the frequency of effector memory CD8+ T cells in rhesus monkeys immunized with HIV vaccine","volume":"7","author":"Li","year":"2010","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.nano.2017.11.009_bb0280","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3410\/B2-67","article-title":"Novel roles for IL-15 in T cell survival","volume":"2","author":"Brincks","year":"2010","journal-title":"F1000 Biol Rep"},{"key":"10.1016\/j.nano.2017.11.009_bb0285","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/nature04651","article-title":"Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction","volume":"440","author":"Castellino","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.nano.2017.11.009_bb0290","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/jlb.61.3.246","article-title":"Mig and IP-10: CXC chemokines that target lymphocytes","volume":"61","author":"Farber","year":"1997","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.nano.2017.11.009_bb0295","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1146\/annurev.immunol.18.1.593","article-title":"The role of chemokine receptors in primary, effector, and memory immune responses","volume":"18","author":"Sallusto","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.nano.2017.11.009_bb0300","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1126\/science.270.5243.1811","article-title":"Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells","volume":"270","author":"Cocchi","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.nano.2017.11.009_bb0305","first-page":"162","article-title":"RANTES potentiates antigen-specific mucosal immune responses","volume":"166","author":"Lillard","year":"2001","journal-title":"J Immunol Baltim Md"},{"key":"10.1016\/j.nano.2017.11.009_bb0310","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4049\/jimmunol.172.1.61","article-title":"Sustained IL-12 signaling is required for Th1 development","volume":"172","author":"Athie-Morales","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.nano.2017.11.009_bb0315","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.0105-2896.2006.00400.x","article-title":"Th1 memory: implications for vaccine development","volume":"211","author":"Foulds","year":"2006","journal-title":"Immunol Rev"},{"key":"10.1016\/j.nano.2017.11.009_bb0320","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1038\/ncomms5092","article-title":"Human B cells induce dendritic cell maturation and favour Th2 polarization by inducing OX-40 ligand","volume":"5","author":"Maddur","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.nano.2017.11.009_bb0325","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1126\/science.277.5334.2005","article-title":"Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells","volume":"277","author":"Sallusto","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.nano.2017.11.009_bb0330","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev-immunol-051116-052350","article-title":"Th2 cells in health and disease","volume":"35","author":"Nakayama","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.nano.2017.11.009_bb0335","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/B978-0-12-391858-1.00002-2","article-title":"Gold manno-glyconanoparticles for intervening in HIV gp120 carbohydrate-mediated processes","volume":"509","author":"Di Gianvincenzo","year":"2012","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.nano.2017.11.009_bb0340","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1039\/C2CS35408J","article-title":"Multivalent glycoconjugates as anti-pathogenic agents","volume":"42","author":"Bernardi","year":"2013","journal-title":"Chem Soc Rev"}],"container-title":["Nanomedicine: Nanotechnology, Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963417302046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1549963417302046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,22]],"date-time":"2020-10-22T05:39:46Z","timestamp":1603345186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1549963417302046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1549963417302046"],"URL":"https:\/\/doi.org\/10.1016\/j.nano.2017.11.009","relation":{},"ISSN":["1549-9634"],"issn-type":[{"value":"1549-9634","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Loading dendritic cells with gold nanoparticles (GNPs) bearing HIV-peptides and mannosides enhance HIV-specific T cell responses","name":"articletitle","label":"Article Title"},{"value":"Nanomedicine: Nanotechnology, Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nano.2017.11.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}